Oral sulfonylureas (like glimepiride, glyburide, and tolazamide)
trigger the pancreas to make more insulin.
Review Date: 06/28/2011
Reviewed By: Ari S. Eckman, MD, Chief, Division of Endocrinology, Diabetes and
Metabolism, Trinitas Regional Medical Center, Elizabeth, NJ. Review
provided by VeriMed Healthcare Network. Also reviewed by David
Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
